MariMed seeks stockholder approval for a reverse stock split

September 23, 2026 7:01 AM EDT Send to a Friend
MariMed Inc. (CSE: MRMD) (OTCQB: MRMD) has filed a definitive proxy statement with the U.S. Securities and Exchange Commission seeking ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login